Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02049398 · ClinicalTrials.gov registry record
Study of Variation Over Time in the Oral Microbiome
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 41
- Enrollment target
NCT02049398: Completed study, sponsored by National Cancer Institute (NCI).
NCT02049398 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02049398 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Background: \- Normal bacteria and other tiny organisms are found in healthy human mouths. These are called oral microbiota. It is unclear exactly how the oral microbiota may affect health. For example, if the microbial composition is abnormal, it may lead to mouth conditions like periodontitis. Researchers want to study how the microbiota changes over time. This can help them plan future disease studies. Objectives: \- To see if and how oral microbiota change over time. Eligibility: \- Forty adult employees of the National Cancer Institute Shady Grove. Design: * For 12 hours before the first visit, participants will not eat or drink (except water). They will not brush, floss, use mouthwash, chew gum, eat lozenges or candies, smoke cigarettes, or chew tobacco. * At the first visit, participants will: * Be given a saliva collector. They will spit 2 mL of saliva into it. * Fill out an online questionnaire. * Every 2 months, participants will visit the clinic and repeat visit 1. * The study ends after 1 year. Sponsoring Institute: National Cancer Institute
Primary Outcome
Stability of oral microbiome over 10 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-01-28 |
| Est. Completion | 2015-12-23 |
What the finished NCT02049398 record still lists
NCT02049398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02049398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02049398 about?
NCT02049398 is a clinical study titled "Study of Variation Over Time in the Oral Microbiome". Background: \- Normal bacteria and other tiny organisms are found in healthy human mouths. These are called oral microbiota. It is unclear exactly how the oral microbiota may affect health. For example, if the microbial composition is abnormal, it may lead to mouth conditions like periodontitis. Re...
What is the current status of trial NCT02049398?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2014-01-28. Estimated completion is 2015-12-23.
Who is sponsoring clinical trial NCT02049398?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI